Login / Signup

Thiamine deficiency in a patient with recurrent renal cell carcinoma who developed weight loss with normal appetite and loss of energy soon after nivolumab treatment.

Hideki OnishiTakashi OkabeNozomu UchidaSuguru ShirotakeMaki TodoMasafumi OyamaMayumi Ishida
Published in: Palliative & supportive care (2021)
In patients treated with nivolumab, it is necessary to pay careful attention to TD when proceeding with the treatment. It is hoped that future research may reveal the link between nivolumab administration and TD.
Keyphrases
  • body mass index
  • weight loss
  • renal cell carcinoma
  • bariatric surgery
  • case report
  • replacement therapy
  • genome wide
  • dna methylation
  • combination therapy